Total Payments
$6,339
2024 Payments
$176.75
Companies
45
Transactions
355
Medicare Patients
1,332
Medicare Billing
$65,947
Payment Breakdown by Category
Food & Beverage$6,276 (99.0%)
Education$63.28 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,276 | 348 | 99.0% |
| Education | $63.28 | 7 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $933.14 | 11 | $0 (2023) |
| ABBVIE INC. | $908.03 | 66 | $0 (2024) |
| Novo Nordisk Inc | $573.57 | 44 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $500.58 | 30 | $0 (2024) |
| Amgen Inc. | $357.28 | 22 | $0 (2023) |
| Lilly USA, LLC | $335.36 | 26 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $307.46 | 17 | $0 (2023) |
| PFIZER INC. | $248.50 | 16 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $231.73 | 19 | $0 (2023) |
| Ascensia Diabetes Care Us Inc. | $219.73 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $176.75 | 9 | ABBVIE INC. ($67.88) |
| 2023 | $2,901 | 166 | ABBVIE INC. ($463.70) |
| 2022 | $1,417 | 81 | AstraZeneca Pharmaceuticals LP ($289.08) |
| 2021 | $1,844 | 99 | AstraZeneca Pharmaceuticals LP ($449.88) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: GI | ||||||
| 02/27/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: GI | ||||||
| 02/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: UROLOGY | ||||||
| 01/16/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: ADHD | ||||||
| 01/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/08/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardio-renal | ||||||
| 12/22/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/21/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Bone Health | ||||||
| 12/18/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardio-renal | ||||||
| 12/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/30/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: UROLOGY | ||||||
| 11/23/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: VACCINES | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Bone Health | ||||||
| 11/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 402 | 515 | $88,598 | $19,687 |
| 2022 | 15 | 930 | 1,531 | $132,301 | $46,260 |
Total Patients
1,332
Total Services
2,046
Medicare Billing
$65,947
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 169 | $38,086 | $6,841 | 18.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 54 | 54 | $15,030 | $5,481 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 84 | $26,341 | $5,190 | 19.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 76 | 100 | $1,780 | $840.00 | 47.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $2,618 | $562.24 | 21.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 40 | $2,953 | $380.80 | 12.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $1,319 | $288.80 | 21.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 28 | 30 | $472.00 | $102.30 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 485 | $64,940 | $21,374 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 135 | 135 | $31,430 | $14,304 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 24 | $7,932 | $2,562 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 34 | $7,678 | $2,237 | 29.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 20 | 20 | $2,215 | $1,397 | 63.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 48 | 96 | $3,900 | $920.83 | 23.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 148 | 225 | $3,425 | $767.73 | 22.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 167 | 225 | $2,290 | $663.18 | 29.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $590.00 | $542.79 | 92.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 20 | 21 | $2,132 | $420.03 | 19.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 47 | 115 | $1,725 | $373.05 | 21.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 43 | 56 | $794.00 | $345.88 | 43.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 26 | $1,150 | $138.01 | 12.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 20 | 24 | $1,050 | $118.22 | 11.3% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 20 | 24 | $1,050 | $96.05 | 9.1% |
About Amanda Worner, ARNP
Amanda Worner, ARNP is a Family healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1780014944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Worner, ARNP has received a total of $6,339 in payments from pharmaceutical and medical device companies, with $176.75 received in 2024. These payments were reported across 355 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,276).
As a Medicare-enrolled provider, Worner has provided services to 1,332 Medicare beneficiaries, totaling 2,046 services with total Medicare billing of $65,947. Data is available for 2 years (2022–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Omaha, NE
- Active Since 11/25/2013
- Last Updated 12/22/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1780014944
Products in Payments
- Kerendia (Drug) $500.58
- BREZTRI (Drug) $422.21
- UBRELVY (Drug) $316.72
- REXULTI (Drug) $307.46
- Ozempic (Drug) $283.85
- VRAYLAR (Drug) $257.21
- QULIPTA (Drug) $246.27
- ELIQUIS (Drug) $220.86
- AIRSUPRA (Drug) $180.00
- BEVESPI AEROSPHERE (Drug) $164.36
- FARXIGA (Drug) $152.39
- TRULICITY (Drug) $142.10
- MOUNJARO (Drug) $142.00
- GEMTESA (Drug) $140.81
- ZENPEP (Drug) $140.27
- Otezla (Drug) $137.09
- Rybelsus (Drug) $118.27
- EVENITY (Biological) $107.63
- Linzess (Drug) $100.74
- AFREZZA (Drug) $98.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Omaha
Stephanie Simon, Aprn, APRN
Family — Payments: $154,278
Family $154,278
Laura Falcone, Aprn, APRN
Family — Payments: $25,682
Family $25,682
Ladeana Smedlund, Aprn, APRN
Family — Payments: $20,139
Family $20,139
Ms. Christina Hadley, Aprn Np-C, APRN NP-C
Family — Payments: $10,623
Family $10,623
Sara Legleiter, Aprn, APRN
Family — Payments: $9,281
Family $9,281
Brittany Matney, Dnp-Fnp, DNP-FNP
Family — Payments: $9,196
Family $9,196